Literature DB >> 6208119

Production and characterization of monoclonal antibody to a melanoma specific glycoprotein.

A C Morgan, D R Galloway, R A Reisfeld.   

Abstract

An immunogen consisting of a 4M urea extract derived from human melanoma cells (M14), that was devoid of HLA-A,B,C, HLA-DR antigens and fibronectin was adsorbed to lens culinaris lectin-Sepharose 4B and used to immunize mice for production of monoclonal antibody to a melanoma-specific glycoprotein. Screening for hybridomas secreting antibodies to melanoma associated antigens was facilitated by use of a solid phase target antigen of chemically defined medium of melanoma cells (CDM). Use of these procedures allowed us to select 40 hybridomas secreting antibody which recognized determinants on melanoma cells not found on lymphoid cells. Further characterization of one of these hybridomas, 9.2.27, indicated that the antibody it secreted recognized a 240K dalton glycoprotein found on all melanoma cell lines tested but not on carcinoma, lymphoid, or fibroblastoid cultures. These results demonstrate the utility of soluble antigen preparations devoid of strongly immunogenic non tumor-specific molecules in the elicitation of tumor specific antibody. Preliminary results suggest that immunogens of this kind are superior to intact melanoma cells for production of tumor specific hybridomas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6208119     DOI: 10.1089/hyb.1.1981.1.27

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  30 in total

1.  Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.

Authors:  Hong Zhou; Yuying Liu; Lawrence H Cheung; Sehoon Kim; Weihe Zhang; Khalid A Mohamedali; Preetha Anand; Walter N Hittelman; Bharat B Aggarwal; Michael G Rosenblum
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Methods for determination of growth-rate-dependent changes in hybridoma volume, shape and surface structure during continuous recycle.

Authors:  N K Goebel; R Kuehn; M C Flickinger
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

3.  Improved methods for investigating the external redox potential in hybridoma cell culture.

Authors:  S B Pluschkell; M C Flickinger
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

4.  Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

5.  Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling.

Authors:  Ase Bratland; Piet J Boender; Hanne K Høifødt; Ingrid H G Østensen; Rob Ruijtenbeek; Meng-Yu Wang; Jens P Berg; Wolfgang Lilleby; Øystein Fodstad; Anne Hansen Ree
Journal:  Clin Exp Metastasis       Date:  2009-03-18       Impact factor: 5.150

6.  Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.

Authors:  G Schulz; T F Bumol; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

Authors:  A R Fritzberg; P G Abrams; P L Beaumier; S Kasina; A C Morgan; T N Rao; J M Reno; J A Sanderson; A Srinivasan; D S Wilbur
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 8.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo.

Authors:  Melissa C Cheung; Leigh Revers; Subodini Perampalam; Xin Wei; Reza Kiarash; David E Green; Aws Abdul-Wahid; Jean Gariépy
Journal:  Mol Cancer       Date:  2010-02-03       Impact factor: 27.401

10.  Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma.

Authors:  Lina Prasmickaite; Birgit Ø Engesaeter; Nirma Skrbo; Tina Hellenes; Alexandr Kristian; Nina K Oliver; Zhenhe Suo; Gunhild M Maelandsmo
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.